C

CytoTools AG
XETRA:T5O

Watchlist Manager
CytoTools AG
XETRA:T5O
Watchlist
Price: 101.26 EUR 0.98% Market Closed
Market Cap: 52.8m EUR
Have any thoughts about
CytoTools AG?
Write Note

CytoTools AG
Total Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

CytoTools AG
Total Receivables Peer Comparison

Comparables:
BNTX
MOR
IMTX
BIO
FYB

Competitive Total Receivables Analysis
Latest Figures & CAGR of Competitors

Company Total Receivables CAGR 3Y CAGR 5Y CAGR 10Y
C
CytoTools AG
XETRA:T5O
Total Receivables
€50.5k
CAGR 3-Years
4%
CAGR 5-Years
-29%
CAGR 10-Years
-14%
BioNTech SE
NASDAQ:BNTX
Total Receivables
€2.3B
CAGR 3-Years
139%
CAGR 5-Years
142%
CAGR 10-Years
N/A
MorphoSys AG
XETRA:MOR
Total Receivables
€30.8m
CAGR 3-Years
-33%
CAGR 5-Years
8%
CAGR 10-Years
-12%
Immatics NV
NASDAQ:IMTX
Total Receivables
€5.7m
CAGR 3-Years
26%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biotest AG
XETRA:BIO
Total Receivables
€171m
CAGR 3-Years
0%
CAGR 5-Years
4%
CAGR 10-Years
1%
Formycon AG
XETRA:FYB
Total Receivables
€28.3m
CAGR 3-Years
54%
CAGR 5-Years
41%
CAGR 10-Years
N/A

See Also

What is CytoTools AG's Total Receivables?
Total Receivables
50.5k EUR

Based on the financial report for Jun 30, 2023, CytoTools AG's Total Receivables amounts to 50.5k EUR.

What is CytoTools AG's Total Receivables growth rate?
Total Receivables CAGR 10Y
-14%

Over the last year, the Total Receivables growth was 20%. The average annual Total Receivables growth rates for CytoTools AG have been 4% over the past three years , -29% over the past five years , and -14% over the past ten years .

Back to Top